LON:SPH

Sinclair Pharma (SPH) Share Price, News & Analysis

GBX 31.80
0.00 (0.00%)
(As of 11/5/2018)
Today's Range
31.80
31.80
50-Day Range
31.80
31.80
52-Week Range
14.45
32
Volume
373,221 shs
Average Volume
3.30 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SPH stock logo

About Sinclair Pharma Stock (LON:SPH)

Sinclair Pharma plc, a specialty pharmaceutical company, engages in the manufacture, commercialization, and sale of dermatological products worldwide. It provides Silhouette Soft, a resorbable poly-L-lactic acid(PLLA)/PLGA suture with bi-directional resorbable cones for skin repositioning and tightening; and Ellansé, which offers dermal fillers. The company also provides Perfectha for wrinkle correction, facial contouring, and volume restoration; and Sculptra designed to stimulate collagen growth. It serves healthcare providers and plastic surgeons. The company was formerly known as Sinclair IS Pharma plc and changed its name to Sinclair Pharma plc in December 2015. Sinclair Pharma plc was founded in 1971 and is headquartered in London, the United Kingdom.

SPH Stock Price History

SPH Stock News Headlines

A new way to collect income from stocks
Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…
Cheryl Sinclair
Dr. Robert Sinclair
Sinclair Continues To Face Challenges
PRISCILLA A. SINCLAIR
Christine A. Sinclair
A new way to collect income from stocks
Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…
Dr. William R. Sinclair
Dr. Peter Sinclair
Tiffany Sinclair
Dr. Cassandra S. Sinclair
Sinclair Reports Second Quarter 2022 Financial Results
Sinclair Pharma Share Chat
See More Headlines
Receive SPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sinclair Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Major
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Christopher P. Spooner
    CEO & Exec. Director
  • Mr. Alan Musgrave Olby (Age 47)
    CFO & Director
  • Ms. Jayne Burrell (Age 43)
    Group Gen. Counsel & Company Sec.
  • Ms. Emilie Croissant
    Head of Europe & Global Marketing
  • Mr. Nairn McMaster
    Head of Latin America

SPH Stock Analysis - Frequently Asked Questions

How have SPH shares performed in 2024?

Sinclair Pharma's stock was trading at GBX 31.80 on January 1st, 2024. Since then, SPH shares have increased by 0.0% and is now trading at GBX 31.80.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Sinclair Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sinclair Pharma investors own include Vectura Group (VEC), Energy Transfer (ET), Hikma Pharmaceuticals (HIK), ASOS (ASC), Cracker Barrel Old Country Store (CBRL), Jack in the Box (JACK).

How do I buy shares of Sinclair Pharma?

Shares of SPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:SPH) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners